The chart below shows how PHR performed 10 days before and after its earnings report, based on data from the past quarters. Typically, PHR sees a +1.31% change in stock price 10 days leading up to the earnings, and a +7.80% change 10 days following the report. On the earnings day itself, the stock moves by -0.39%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Revenue Increase 17%: Revenue was $106.8 million, up 17% year-over-year.
Adjusted EBITDA Increase: Adjusted EBITDA was $9.8 million, up $16.4 million year-over-year with an adjusted EBITDA margin of 9%.
Client Growth in Health Care: Average health care services clients or AHSCS increased by 68 from the prior quarter.
Revenue Per AHSCS Growth: Total revenue per AHSCS was $25,207, up 1% year-over-year and up 3% over the previous quarter.
Positive Cash Flow Increase: Operating cash flow was positive at $5.8 million, up $12.1 million year-over-year.
Negative
Revenue Growth Slowdown: Revenue growth was only 1% year-over-year, indicating a slowdown compared to previous quarters.
Client Revenue Decline: Total revenue per AHS client decreased by 2% year-over-year, reflecting challenges in client retention and engagement.
EBITDA Margin Analysis: The adjusted EBITDA margin was reported at 9%, which is significantly lower than industry benchmarks, indicating potential inefficiencies in operations.
Cash Flow Decline Concerns: Operating cash flow showed a decline of $12.1 million year-over-year, raising concerns about liquidity and operational efficiency.
Revenue Outlook Revision: The company revised its revenue outlook for fiscal 2025 down to a range of $418 million to $420 million, from a previous estimate of $416 million to $426 million, signaling weaker than expected demand.
Phreesia, Inc. (PHR) Q3 2025 Earnings Call Transcript
PHR.N
-1.86%